A rare cause of hydrops fetalis in two Gaucher disease type 2 patients with a novel mutation.
GBA
Gaucher disease
Ichthyosis
hydrops fetalis
Journal
Metabolic brain disease
ISSN: 1573-7365
Titre abrégé: Metab Brain Dis
Pays: United States
ID NLM: 8610370
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
17
11
2021
accepted:
22
02
2022
pubmed:
8
3
2022
medline:
29
4
2022
entrez:
7
3
2022
Statut:
ppublish
Résumé
Gaucher disease type 2 is the most progressive and the rarest form of Gaucher disease, defined as the acute neuronopathic type. We presented two GD2 patients who died before three months of age due to severe septicemia, respiratory and liver failure. One was homozygous for a novel GBA variant c.590 T > A (p.197 K), and the second homozygous for the known GBA mutation c.1505G > A (p.R502H). Ichthyosis, hydrops fetalis, apnea, myoclonic seizures, and hepatosplenomegaly occurred in both patients, but hypertrophic cardiomyopathy was observed only in the second and unilateral cataract in the first patient. Due to the disease's early and rapid neurological progression, we did not administer ERT to our patients. It is strongly believed that early diagnosis is essential, and prenatal diagnosis makes genetic counselling possible for future pregnancies.
Identifiants
pubmed: 35254599
doi: 10.1007/s11011-022-00942-5
pii: 10.1007/s11011-022-00942-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1283-1287Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Akdag A, Oguz SS, Ezgu F, Erdeve O, Uras N, Dilmen U (2011) A newborn case with perinatal-lethal Gaucher disease due to R463H homozygosity complicated by C677T homozygosity in the MTHFR gene. J Pediatr Endocrinol Metab 24(5-6):381–383. https://doi.org/10.1515/jpem.2011.001
doi: 10.1515/jpem.2011.001
pubmed: 21823541
Alfonso P, Aznarez S, Giralt M, Pocovi M, Giraldo P, Spanish Gaucher's Disease, R (2007) Mutation analysis and genotype/phenotype relationships of Gaucher disease patients in Spain. J Hum Genet 52(5):391–396. https://doi.org/10.1007/s10038-007-0135-4
doi: 10.1007/s10038-007-0135-4
pubmed: 17427031
BenHamida E, Ayadi I, Ouertani I, Chammem M, Bezzine A, BenTmime R et al (2015) Perinatal-lethal Gaucher disease presenting as hydrops fetalis. Pan Afr Med J 21:110. https://doi.org/10.11604/pamj.2015.21.110.7052
doi: 10.11604/pamj.2015.21.110.7052
pubmed: 26327947
pmcid: 4546719
Bronstein S, Karpati M, Peleg L (2014) An update of Gaucher mutations distribution in the Ashkenazi Jewish population: prevalence and country of origin of the mutation R496H. Isr Med Assoc J 16(11):683–685 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25558695
pubmed: 25558695
Bulut FD, Kor D, Seker-Yilmaz B, Herguner O, Ceylaner S, Ozkinay F et al (2018) Four Gaucher disease type II patients with three novel mutations: a single Centre experience from Turkey. Metab Brain Dis 33(4):1223–1227. https://doi.org/10.1007/s11011-018-0236-0
doi: 10.1007/s11011-018-0236-0
pubmed: 29656334
Campbell PE, Harris CM, Harris CM, Sirimanna T, Vellodi A (2003) A model of neuronopathic Gaucher disease. J Inherit Metab Dis 26(7):629–639. https://doi.org/10.1023/b:boli.0000005619.14180.5c
doi: 10.1023/b:boli.0000005619.14180.5c
pubmed: 14707511
Daykin EC, Ryan E, Sidransky E (2021) Diagnosing neuronopathic Gaucher disease: new considerations and challenges in assigning Gaucher phenotypes. Mol Genet Metab 132(2):49–58. https://doi.org/10.1016/j.ymgme.2021.01.002
doi: 10.1016/j.ymgme.2021.01.002
pubmed: 33483255
pmcid: 7884077
Eblan MJ, Goker-Alpan O, Sidransky E (2005) Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum. Fetal Pediatr Pathol 24(4-5):205–222. https://doi.org/10.1080/15227950500405296
doi: 10.1080/15227950500405296
pubmed: 16396828
Grace ME, Balwani M, Nazarenko I, Prakash-Cheng A, Desnick RJ (2007) Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutations-implications for diagnosis and therapeutic monitoring. Hum Mutat 28(9):866–873. https://doi.org/10.1002/humu.20524
doi: 10.1002/humu.20524
pubmed: 17464953
Haverkaemper S, Marquardt T, Hausser I, Timme K, Kuehn T, Hertzberg C, Rossi R (2011) Congenital ichthyosis in severe type II Gaucher disease with a homozygous null mutation. Neonatology 100(2):194–197. https://doi.org/10.1159/000324116
doi: 10.1159/000324116
pubmed: 21455010
Inui K, Yanagihara K, Otani K, Suzuki Y, Akagi M, Nakayama M et al (2001) A new variant neuropathic type of Gaucher's disease characterized by hydrocephalus, corneal opacities, deformed toes, and fibrous thickening of spleen and liver capsules. J Pediatr 138(1):137–139. https://doi.org/10.1067/mpd.2001.109789
doi: 10.1067/mpd.2001.109789
pubmed: 11148530
Kooper AJ, Janssens PM, de Groot AN, Liebrand-van Sambeek ML, van den Berg CJ, Tan-Sindhunata GB, ..., Wevers RA (2006) Lysosomal storage diseases in non-immune hydrops fetalis pregnancies. Clin Chim Acta 371(1-2): 176–182. https://doi.org/10.1016/j.cca.2006.03.007
Koprivica V, Stone DL, Park JK, Callahan M, Frisch A, Cohen IJ et al (2000) Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet 66(6):1777–1786. https://doi.org/10.1086/302925
doi: 10.1086/302925
pubmed: 10796875
pmcid: 1378059
Lui K, Commens C, Choong R, Jaworski R (1988) Collodion babies with Gaucher's disease. Arch Dis Child 63(7):854–856. https://doi.org/10.1136/adc.63.7.854
doi: 10.1136/adc.63.7.854
pubmed: 3415310
pmcid: 1779077
Migita M, Hamada H, Fujimura J, Watanabe A, Shimada T, Fukunaga Y (2003) Glucocerebrosidase level in the cerebrospinal fluid during enzyme replacement therapy--unsuccessful treatment of the neurological abnormality in type 2 Gaucher disease. Eur J Pediatr 162(7-8):524–525. https://doi.org/10.1007/s00431-001-0859-7
doi: 10.1007/s00431-001-0859-7
pubmed: 12845529
Mignot C, Gelot A, Bessieres B, Daffos F, Voyer M, Menez F et al (2003) Perinatal-lethal Gaucher disease. Am J Med Genet A 120A(3):338–344. https://doi.org/10.1002/ajmg.a.20117
doi: 10.1002/ajmg.a.20117
pubmed: 12838552
Nagappa M, Bindu PS, Taly AB, Sinha S (2015) Oculomotor apraxia in Gaucher disease. Pediatr Neurol 52(4):468–469. https://doi.org/10.1016/j.pediatrneurol.2014.10.016
doi: 10.1016/j.pediatrneurol.2014.10.016
pubmed: 25687160
Pastores GM, Hughes DA (1993) Gaucher Disease. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A (eds) GeneReviews((R)), Seattle (WA)
Plakkal N, Soraisham AS, Jirapradittha J, Pinto-Rojas A (2011) Perinatal lethal Gaucher disease. Indian J Pediatr 78(1):106–108. https://doi.org/10.1007/s12098-010-0247-2
doi: 10.1007/s12098-010-0247-2
pubmed: 20924719
Roshan Lal T, Sidransky E (2017) The Spectrum of neurological manifestations associated with Gaucher disease. Diseases 5(1). https://doi.org/10.3390/diseases5010010
Roshan Lal T, Seehra GK, Steward AM, Poffenberger CN, Ryan E, Tayebi N et al (2020) The natural history of type 2 Gaucher disease in the 21st century: a retrospective study. Neurology 95(15):e2119–e2130. https://doi.org/10.1212/WNL.0000000000010605
doi: 10.1212/WNL.0000000000010605
pubmed: 32764102
pmcid: 7713752
Staretz-Chacham O, Lang TC, LaMarca ME, Krasnewich D, Sidransky E (2009) Lysosomal storage disorders in the newborn. Pediatrics 123(4):1191–1207. https://doi.org/10.1542/peds.2008-0635
doi: 10.1542/peds.2008-0635
pubmed: 19336380
Stone DL, Carey WF, Christodoulou J, Sillence D, Nelson P, Callahan M et al (2000a) Type 2 Gaucher disease: the collodion baby phenotype revisited. Arch Dis Child Fetal Neonatal Ed 82(2):F163–F166. https://doi.org/10.1136/fn.82.2.f163
doi: 10.1136/fn.82.2.f163
pubmed: 10685993
pmcid: 1721053
Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E (2000b) Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat 15(2):181–188. https://doi.org/10.1002/(SICI)1098-1004(200002)15:2<181::AIDHUMU7>3.0.CO;2-S
doi: 10.1002/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S
pubmed: 10649495
Weiss K, Gonzalez A, Lopez G, Pedoeim L, Groden C, Sidransky E (2015) The clinical management of type 2 Gaucher disease. Mol Genet Metab 114(2):110–122. https://doi.org/10.1016/j.ymgme.2014.11.008
doi: 10.1016/j.ymgme.2014.11.008
pubmed: 25435509